Paper
0
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
Authors
Hossein Ghofrani,Gérald Simonneau
Andrea D’Armini,Peter Fedullo,Luke Howard,Xavier Jaïs,David Jenkins,Zhi‐Cheng Jing,Michael Madani,Nicolas Martin,Eckhard Mayer,Kelly Papadakis,Dominik Richard,Nick Kim,Iréne Lang,Christian Kähler,Marion Delcroix,Zoheir Bshouty,Pablo Varela,Yuanhua Yang,Jinming Liu,Gangcheng Zhang,Nuofu Zhang,Yuhong Mi,Xianyang Zhu,P Jansa,Grégoire Prévôt,Hélène Bouvaist,Olivier Sanchez,Friedrich Grimminger,Matthias Held,Heinrike Wilkens,Stephan Rosenkranz,Ekkehard Grünig,Kristóf Karlócai,A Temesvári,István Édes,Sigita Aidietienė,Skaidrius Miliauskas,Tomás Zamudio,Carlos Sánchez,Anton Noordegraaf,Jerzy Lewczuk,Piotr Podolec,Jarosław Kasprzak,Tatiana Mularek‐Kubzdela,Ryszard Grzywna,Keertan Dheda,О. Моисеева,A. Chernyavskiy,В. Шипулин,О. Барбараш,T. Martynyuk,Hyung‐Kwan Kim,Jun‐Bean Park,Jae Lee,Rudolf Speich,Silvia Ulrich,John‐David Aubert,Arintaya Phrommintikul,Nattapong Jaimchariyatam,Suree Sompradeekul,Zeynep Önen,Gülfer Okumuş,Lyubomyr Solovey,Volodymyr Gavrysyuk,Joanna Pepke‐Żaba,Robin Condliffe,John McConnell,Kim Kerr,Lan Nguyen,Nguyen Pham,Anton Vonk‐Noordegraaf,Irene Lang
+72 authors
,Joanna Pepke‐ZabaPublished
Sep 11, 2017
Show more
Save
Tip0
TipSave